The anti-cancer mechanisms of ciclopirox are complex and include the inhibition of Wnt/β-catenin, histone demethylases/Myc, VEGFR-3/ERK1/2, cyclin-dependent kinases, and mTORC1 and the induction of reactive oxygen species or activation of ATR/Chk (68). Here, MYC is linked to cancer.